BiotechTube

4 mg CLS-TA Suprachoriodal Injection

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Uveitis

Conditions

Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate, Panuveitis

Trial Timeline

Apr 4, 2017 → Jan 24, 2018

NCT ID
NCT03097315

About 4 mg CLS-TA Suprachoriodal Injection

4 mg CLS-TA Suprachoriodal Injection is a phase 3 stage product being developed by Clearside Biomedical for Uveitis. The current trial status is completed. This product is registered under clinical trial identifier NCT03097315. Target conditions include Uveitis, Uveitis, Posterior, Uveitis, Anterior.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03097315Phase 3Completed

Competing Products

20 competing products in Uveitis

See all competitors
ProductCompanyStageHype Score
triamcinolone acetonide (Triesence®)Clearside BiomedicalPhase 1/2
33
Baricitinib + AdalimumabEli LillyPhase 3
77
Ixekizumab Prefilled SyringeEli LillyApproved
85
adalimumabAbbViePhase 3
77
Adalimumab + Prednisone + PlaceboAbbViePhase 3
77
Adalimumab + Prednisone + PlaceboAbbViePhase 3
77
AdalimumabAbbVieApproved
85
FTY720 + Oral CorticosteroidNovartisPhase 2
52
AIN457NovartisPhase 3
77
MyforticNovartisPre-clinical
23
AIN457 + AIN457 + Placebo AIN457NovartisPhase 3
77
LFG316 + Conventional TherapyNovartisPhase 2
52
RanibizumabNovartisPhase 2
52
AIN457 + PlaceboNovartisPhase 3
77
AIN457 + AIN457 + AIN457 + PlaceboNovartisPhase 3
77
AEB071NovartisPhase 2
52
AIN457 + AIN457 + AIN457 + PlaceboNovartisPhase 3
77
Myfortic + DecortinNovartisPhase 3
77
AIN457 + AIN 457 + AIN457NovartisPhase 2
52
AIN457 + AIN457 + AIN457 + PlaceboNovartisPhase 3
77

Other Products from Clearside Biomedical

suprachoroidal CLS-TA + suprachoroidal sham + Lucentis or AvastinPhase 3
69
4mg CLS-TA Suprachoriodal Injection + Sham ProcedurePhase 3
69
suprachoroidal CLS-TA + suprachoroidal sham + IVT afliberceptPhase 3
69
4 mg CLS-TA + Sham + IVT afliberceptPhase 2
44
CLS-AX + AfliberceptPhase 2
44